Responses
Regular and young investigator award abstracts
Checkpoint blockade therapy
191 Association of immune related adverse events with the efficacy of immune checkpoint inhibitors in metastatic renal cell carcinoma
Compose a Response to This Article
Other responses
No responses have been published for this article.
